Literature DB >> 12224070

Decreased first trimester PAPP-A is a predictor of adverse pregnancy outcome.

Yuval Yaron1, Sigal Heifetz, Yifat Ochshorn, Ofer Lehavi, Avi Orr-Urtreger.   

Abstract

OBJECTIVE: Low levels of maternal serum pregnancy associated plasma protein-A (PAPP-A) have been linked to chromosome anomalies such as trisomy 21, 13 and 18, triploidy and sex chromosome aneuploidy. Low levels of PAPP-A have also been implicated in spontaneous miscarriage. The purpose of this study was to evaluate whether low levels of first trimester PAPP-A are predictive of other adverse pregnancy outcomes. STUDY
DESIGN: The study included patients with singleton pregnancies who underwent combined first trimester screening using nuchal translucency (NT) and maternal serum free beta-human chorionic gonadotrophin (free beta-hCG) and PAPP-A at 10-13 weeks' gestation. Patients with chromosome aberrations or fetal anomalies were excluded. Serum marker levels were expressed as gestational age-specific multiples of the median (MoMs). The incidences of various adverse pregnancy outcomes (spontaneous preterm labor, fetal growth restriction (FGR), proteinuric and non-proteinuric pregnancy induced hypertension (PIH), intrauterine fetal demise, oligohydramnios, spontaneous miscarriage and placental abruption) were evaluated, according to maternal PAPP-A MoM levels.
RESULTS: Of the 1622 patients in the study, pregnancy complications were observed in 184 (11.3%). Patients with PAPP-A < or =0.25 MoM had significantly higher rates of FGR (RR = 3.12), proteinuric PIH (RR = 6.09), spontaneous miscarriage (RR = 8.76). No statistically significant differences were noted for other adverse outcomes evaluated Women with PAPP-A < or =0.50 MoM also had significantly higher rates of FGR (RR = 3.30) and spontaneous miscarriage (RR = 3.78).
CONCLUSIONS: We conclude that decreased levels of first trimester maternal serum PAPP-A are predictive not only of chromosome anomalies but also of adverse pregnancy outcome. Copyright 2002 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12224070     DOI: 10.1002/pd.407

Source DB:  PubMed          Journal:  Prenat Diagn        ISSN: 0197-3851            Impact factor:   3.050


  34 in total

Review 1.  Role of biomarkers in early detection of preeclampsia.

Authors:  Manisha Kar
Journal:  J Clin Diagn Res       Date:  2014-04-15

2.  Changes in first trimester screening test parameters in pregnancies complicated by placenta previa and association with hyperemesis gravidarum.

Authors:  Fırat Tülek; Alper Kahraman; Salih Taşkın; Esra Özkavukçu; Feride Söylemez
Journal:  J Turk Ger Gynecol Assoc       Date:  2014-12-01

3.  The use of ultrasound and other markers for early detection of preeclampsia.

Authors:  Neil O'Gorman; Kypros H Nicolaides; Liona C Y Poon
Journal:  Womens Health (Lond)       Date:  2016-02-22

4.  Predicting the risk of pre-eclampsia between 11 and 13 weeks' gestation by combining maternal characteristics and serum analytes, PAPP-A and free β-hCG.

Authors:  Katherine R Goetzinger; Ashima Singla; Sabrina Gerkowicz; Jeffrey M Dicke; Diana L Gray; Anthony O Odibo
Journal:  Prenat Diagn       Date:  2010-12       Impact factor: 3.050

5.  First-Trimester and Second-Trimester Maternal Serum Biomarkers as Predictors of Placental Abruption.

Authors:  Cande V Ananth; Ronald J Wapner; Srinidhi Ananth; Mary E DʼAlton; Anthony M Vintzileos
Journal:  Obstet Gynecol       Date:  2017-03       Impact factor: 7.661

6.  Low maternal serum pregnancy-associated plasma protein-A as a risk factor of preeclampsia.

Authors:  Suchaya Luewan; Monrudee Teja-Intr; Supatra Sirichotiyakul; Theera Tongsong
Journal:  Singapore Med J       Date:  2017-04-28       Impact factor: 1.858

Review 7.  Serum screening with Down's syndrome markers to predict pre-eclampsia and small for gestational age: systematic review and meta-analysis.

Authors:  Rachel K Morris; Jeltsje S Cnossen; Marloes Langejans; Stephen C Robson; Jos Kleijnen; Gerben Ter Riet; Ben W Mol; Joris A M van der Post; Khalid S Khan
Journal:  BMC Pregnancy Childbirth       Date:  2008-08-04       Impact factor: 3.007

8.  Prediction of adverse pregnancy outcomes by extreme values of first trimester screening markers.

Authors:  Marina S Gomes; Mariana Carlos-Alves; Vera Trocado; Diana Arteiro; Paula Pinheiro
Journal:  Obstet Med       Date:  2017-05-16

Review 9.  Potential markers of preeclampsia--a review.

Authors:  Simon Grill; Corinne Rusterholz; Rosanna Zanetti-Dällenbach; Sevgi Tercanli; Wolfgang Holzgreve; Sinuhe Hahn; Olav Lapaire
Journal:  Reprod Biol Endocrinol       Date:  2009-07-14       Impact factor: 5.211

10.  Record linkage to obtain birth outcomes for the evaluation of screening biomarkers in pregnancy: a feasibility study.

Authors:  Samantha J Lain; Charles S Algert; Vitomir Tasevski; Jonathan M Morris; Christine L Roberts
Journal:  BMC Med Res Methodol       Date:  2009-07-09       Impact factor: 4.615

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.